Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Identification of a ligand for the death-domain-containing receptor Apo3.

Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A.

Curr Biol. 1998 Apr 23;8(9):525-8.

2.
3.

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.

Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A.

Curr Biol. 1996 Dec 1;6(12):1669-76.

4.

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).

Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J.

Immunity. 1997 Jan;6(1):79-88.

6.
7.

Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.

Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV.

Oncogene. 2001 Nov 29;20(55):7965-75.

8.

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.

Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A.

J Biol Chem. 1996 May 31;271(22):12687-90.

9.

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C.

J Neurosci. 2006 Mar 22;26(12):3299-308. Erratum in: J Neurosci. 2006 May 3;26(18):4983.

10.

TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.

Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S.

Blood. 2003 May 1;101(9):3658-67. Epub 2002 Dec 27.

11.

Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.

Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.

Hum Immunol. 2005 Jul;66(7):799-809.

PMID:
16112027
13.

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.

Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.

Oncogene. 2004 Aug 12;23(36):6083-94.

PMID:
15208670
14.

TRAIL-induced signalling and apoptosis.

MacFarlane M.

Toxicol Lett. 2003 Apr 4;139(2-3):89-97. Review.

PMID:
12628743
15.

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D, Dobles M, Hertig S, Hofmann K, Van Vlijmen H, Hsu YM, Burkly LC, Tschopp J, Zheng TS.

J Biol Chem. 2003 Feb 14;278(7):5444-54. Epub 2002 Dec 3.

19.

Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).

Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P.

J Biol Chem. 2000 Aug 11;275(32):24357-66.

20.

Supplemental Content

Support Center